Text Size

Executive Dysfunction & Suicide: An Exploration Of Risk Factors In Traumatically Brain Injured Veterans

This study has been completed.
Sponsor:
Information provided by:
VA Eastern Colorado Health Care System
ClinicalTrials.gov Identifier:
NCT01118195
First received: May 4, 2010
Last updated: April 21, 2011
Last verified: April 2011
History of Changes
  Purpose

This is a study to learn more about traumatic brain injury (TBI) and suicidal behaviors. The purpose of this research is to find out more about the issues related to these conditions. This study seeks to explore the relationship between executive dysfunction and suicidal behavior in an outpatient population.


Condition
Traumatic Brain Injury (TBI)
Suicidal Behavior

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Executive Dysfunction & Suicide: An Exploration Of Risk Factors In Traumatically Brain Injured Veterans

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by VA Eastern Colorado Health Care System:

Estimated Enrollment: 54
Study Start Date: January 2007
Study Completion Date: April 2011
Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
TBI and Suicidal Behavior
TBI and No Suicidal Behavior

  Eligibility

Ages Eligible for Study:   18 Years to 74 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

outpatient veterans with a history of traumatic brain injury

Criteria

Inclusion Criteria:

  1. Diagnosis of traumatic brain injury, history of suicidal behavior.
  2. Age 18-74.
  3. Currently receiving care through the Eastern Colorado Health Care System (ECHCS) Denver VA TBI Interdisciplinary Team.

Exclusion Criteria:

  1. History of other significant neurological disease.
  2. Diagnosis of Schizophrenia.
  3. Test of Memory Malingering (TOMM) performance lower than 50%.
  4. Behavior which could be described as Substance Abuse in the 7 days prior to participation.
  5. Current guardianship or mention of recommendation for guardianship in medical chart within the past six months.
  6. Inability to read the informed consent document.
  7. Inability to adequately respond to questions regarding the informed consent procedure.
  8. Significant hearing impairment.
  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Beeta Homaifar, VISN 19 MIRECC
ClinicalTrials.gov Identifier: NCT01118195     History of Changes
Other Study ID Numbers: VA 05-1100
Study First Received: May 4, 2010
Last Updated: April 21, 2011
Health Authority: United States: Federal Government
United States: Institutional Review Board

Additional relevant MeSH terms:
Suicide
Brain Injuries
Self-Injurious Behavior
Behavioral Symptoms
Brain Diseases
 Central Nervous System Diseases
Nervous System Diseases
Craniocerebral Trauma
Trauma, Nervous System
Wounds and Injuries

ClinicalTrials.gov processed this record on May 21, 2013